Assessing Surmodics: Insights From 5 Financial Analysts
Assessing Surmodics: Insights From 5 Financial Analysts
评估Surmodics：来自5位金融分析师的见解
Surmodics (NASDAQ:SRDX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有5位分析师对Surmodics（纳斯达克股票代码：SRDX）进行了分析，揭示了从看涨到看跌的不同观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $49.4, a high estimate of $71.00, and a low estimate of $43.00. Experiencing a 16.27% decline, the current average is now lower than the previous average price target of $59.00.
分析师分析的12个月目标股价提供了见解，平均目标价为49.4美元，最高估计为71.00美元，低估值为43.00美元。目前的平均价格下降了16.27％，现在低于之前的平均目标股价59.00美元。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析师评级：深度探索
The perception of Surmodics...
通过最近...
登录免费看全文
登录/注册